Literature DB >> 3863429

Diagnostic value of cytology of voided urine.

L G Koss, D Deitch, R Ramanathan, A B Sherman.   

Abstract

Cytologic examination of the sediment of voided urine is the only noninvasive method of detection, diagnosis and follow-up of tumors of the bladder and other anatomic components of the lower urinary tract. In order to assess the value of cytology of voided urine, we analyzed the diagnostic yield in 203 episodes, each composed of three sediments of voided urine obtained on consecutive days. For each one of these episodes, histologic material was available and was reviewed. Of special interest were 181 instances of primary or recurrent bladder tumors; in 37 of these patients, random biopsies of the bladder were also available for review. The concept of intraurothelial neoplasia (IUN), graded I, II or III, was introduced to describe degrees of atypia in flat urothelium, with IUN grade III corresponding to nonpapillary carcinoma in situ. The results documented that cytology of voided urine is highly reliable in the diagnosis of high-grade tumors, with a sensitivity of 94.2%. In primary flat carcinoma in situ (IUN III), the sensitivity was 100%. The method failed in the recognition of grade I papillary tumors and in about one-third of grade II tumors. There were no false-positive results in this study. In the 151 positive cases, the cytologic diagnosis was established on the first specimen in 79%, on the second specimen in an additional 14% and on the third specimen in 7% of cases. These results justify the use of three consecutive daily urine specimens for optimal diagnostic results. There is a remarkable similarity between the presence of cancer cells in voided urine and the DNA ploidy of bladder tumors, as established by Tribukait. The observations reported herein suggest that positive urine cytologies may correspond to aneuploid tumors and hence be not only of diagnostic but also of prognostic value. A direct proof of this hypothesis is under investigation; the results of this study justify the need for a field trial of an automated image analysis diagnostic system that was developed in this department.

Entities:  

Mesh:

Year:  1985        PMID: 3863429

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  27 in total

1.  Transurethral ultrasonography, fiberoptic cystoscopy and bladder washout cytology in the evaluation of bladder tumours.

Authors:  A Akdaş; L Türkeri; D Ersev; A Ersev; S Kullu
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

2.  Noninvasive diagnostic imaging using machine-learning analysis of nanoresolution images of cell surfaces: Detection of bladder cancer.

Authors:  I Sokolov; M E Dokukin; V Kalaparthi; M Miljkovic; A Wang; J D Seigne; P Grivas; E Demidenko
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-03       Impact factor: 11.205

3.  Adequacy of urine cytology specimens: an assessment of collection techniques.

Authors:  Andrew F Hundley; Susan Maygarden; Jennifer M Wu; Anthony G Visco; AnnaMarie Connolly
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-01-05

4.  [Fluorescence cytology. Improvement of urinary cytology].

Authors:  S Tritschler; S Tauber; R Meier; H Stepp; A Karl; D Zaak; C G Stief
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

5.  Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation.

Authors:  Haythem Dimashkieh; Daynna J Wolff; T Michael Smith; Patricia M Houser; Paul J Nietert; Jack Yang
Journal:  Cancer Cytopathol       Date:  2013-06-25       Impact factor: 5.284

6.  Japanese guidelines of the management of hematuria 2013.

Authors:  Shigeo Horie; Shuichi Ito; Hirokazu Okada; Haruhito Kikuchi; Ichiei Narita; Tsutomu Nishiyama; Tomonori Hasegawa; Hiroshi Mikami; Kunihiro Yamagata; Tomoji Yuno; Satoru Muto
Journal:  Clin Exp Nephrol       Date:  2014-10       Impact factor: 2.801

7.  [Urine cytology and urine markers. Significance for clinical practice].

Authors:  S Tritschler; D Zaak; R Knuechel; C G Stief
Journal:  Urologe A       Date:  2006-11       Impact factor: 0.639

Review 8.  [Urinary cytology. Possibilities, limitations and the future].

Authors:  D Zaak; S Tritschler; R Knuechel; F Vom Dorp; O W Hakenberg; S Hautmann; H Rübben
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

9.  Spectrophotometric photodynamic diagnosis of prostate cancer cells excreted in voided urine using 5-aminolevulinic acid.

Authors:  Yasushi Nakai; Makito Miyake; Satoshi Anai; Shunta Hori; Yoshihiro Tatsumi; Yosuke Morizawa; Sayuri Onisi; Nobumichi Tanaka; Kiyohide Fujimoto
Journal:  Lasers Med Sci       Date:  2018-05-04       Impact factor: 3.161

10.  The efficacy of intravesical BCG in the treatment of patients with high risk superficial bladder cancer.

Authors:  L Samodai; L Kiss; Z Kolozsy; L Mohácsi
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.